FARINA, LUCIA
FARINA, LUCIA
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
2021 A. Dodero, A. Guidetti, F. Marino, A. Tucci, F. Barretta, A. Re, M. Balzarotti, C. Carniti, C. Monfrini, A. Chiappella, A. Cabras, F. Facchetti, M. Pennisi, D. Rahal, V. Monti, L. Devizzi, R. Miceli, F. Cocito, L. Farina, F. Ricci, G. Rossi, C. Carlo-Stella, P. Corradini
Predicting failure of hematopoietic stem cell mobilization before it starts : the predicted poor mobilizer (pPM) score
2018 J. Olivieri, I. Attolico, R. Nuccorini, S.P. Pascale, M. Chiarucci, M. Poiani, P. Corradini, L. Farina, G. Gaidano, L. Nassi, S. Sica, N. Piccirillo, P.E. Pioltelli, M. Martino, T. Moscato, M. Pini, F. Zallio, F. Ciceri, S. Marktel, A. Mengarelli, P. Musto, S. Capria, F. Merli, K. Codeluppi, G. Mele, F. Lanza, G. Specchia, D. Pastore, G. Milone, F. Saraceni, E. Di Nardo, P. Perseghin, A. Olivieri
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma
2018 A. Loglio, M. Viganò, G. Grossi, S. Labanca, M. Goldaniga, A. Pompa, L. Farina, M. Rumi, P. Corradini, F. Facchetti, G. Lunghi, L. Baldini, P. Lampertico
A rare case of atypical chronic lymphocytic leukaemia presenting as nephrotic syndrome
2017 M. Soldarini, L. Farina, A. Genderini, N. Bolli
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen
2017 A. Dodero, F. Patriarca, G. Milone, B. Sarina, R. Miceli, A. Iori, F. Barretta, E. Terruzzi, A. Mussetti, M. Pini, A. Bosi, A. Dominietto, N. Cascavilla, F. Onida, F. Narni, L. Farina, A. Rambaldi, P. Corradini
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
2016 F. Maura, A. Guidetti, A. Pellegrinelli, A. Dodero, M. Pennisi, C. Caprioli, A. Testi, L. Farina, N. Bolli, L.F. Devizzi, A.D. Cabras, P. Corradini
The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era
2016 F. Maura, L. Farina, P. Corradini
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
2014 A. Guidetti, C. Carlo-Stella, S.L. Locatelli, W. Malorni, R. Mortarini, S. Viviani, D. Russo, A. Marchianò, R. Sorasio, A. Dodero, L. Farina, L. Giordano, M. Di Nicola, A. Anichini, P. Corradini, A.M. Gianni
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by pet scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma
2014 L. Farina, F. Rezzonico, F. Spina, A. Dodero, A. Mazzocchi, F. Crippa, A. Alessi, S.C. Dalto, S. Viviani, P. Corradini
Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor : an algorithm for the pre-emptive use of plerixafor
2014 L. Farina, F. Spina, A. Guidetti, P. Longoni, F. Ravagnani, A. Dodero, V. Montefusco, C. Carlo-Stella, P. Corradini
Long-term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemia
2013 F. Spina, F. Rezzonico, L. Farina, P. Corradini
Current state of art for transplantation paradigms in peripheral T-cell lymphomas
2013 G. Perrone, L. Farina, P. Corradini
Allogeneic transplantation for Hodgkin's lymphoma
2011 P. Corradini, B. Sarina, L. Farina
Allogeneic transplantation for lymphoma : long-term outcome
2010 P. Corradini, L. Farina
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia : early assessment can predict long-term outcome after reduced intensity allogeneic transplantation
2009 L. Farina, C. Carniti, A. Dodero, A. Vendramin, A. Raganato, F. Spina, F. Patriarca, F. Narni, F. Benedetti, A. Olivieri, P. Corradini
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
2009 L. Farina, B. Bruno, F. Patriarca, F. Spina, R. Sorasio, M. Morelli, R. Fanin, M. Boccadoro, P. Corradini
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery
2009 A. Dodero, C. Carniti, A. Raganato, A. Vendramin, L. Farina, F. Spina, C. Carlo Stella, S. Di Terlizzi, M. Milanesi, P. Longoni, L. Gandola, C. Lombardo, P. Corradini
CD8-depleted donor lymphocyte infusions can improve both T- and B-cell reconstitution after allogeneic stem cell transplantation from haploidentical family donors
2008 A. Dodero, C. Carniti, A. Raganato, A. Vendramin, S. Di Terlizzi, L. Farina, F. Spina, F. Fossati Bellani, M. Milanesi, P. Longoni, L. Gandola, C. Lombardo, P. Corradini
Qualitative and Quantitative PCR Monitoring of MRD : Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia
2008 L. Farina, C. Carniti, A. Dodero, A. Vendramin, A. Raganato, F. Patriarca, F. Narni, V. Montefusco, F. Benedetti, A. Olivieri, P. Corradini
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft
2008 L. Farina, B. Bruno, F. Patriarca, F. Spina, R. Sorasio, M. Morelli, R. Fanin, M. Boccadoro, P. Corradini